SLC6A4 and drug-induced dyskinesia: For the same reasons that SERT inhibition could lead to an increased availability of dopamine at nigrostriatal synapses, and contribute to anti-parkinsonian benefit, it would also exacerbate of the non-physiological raphestriatal L-DOPA-derived dopaminergic transmission, and exacerbate dyskinesia.